Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

[1]  M. Rao,et al.  Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase , 2011, Cell.

[2]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[3]  Ian Blumenthal,et al.  Type 1 T Helper Cells Induce the Accumulation of Myeloid‐Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver , 2010, Hepatology.

[4]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[5]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[6]  Chris Sander,et al.  The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers , 2009, Proceedings of the National Academy of Sciences.

[7]  T. Mustelin,et al.  A Conserved Mechanism for Control of Human and Mouse Embryonic Stem Cell Pluripotency and Differentiation by Shp2 Tyrosine Phosphatase , 2009, PloS one.

[8]  F. Révillion,et al.  Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer , 2009, International journal of cancer.

[9]  Y. Agazie,et al.  SHP2 is up‐regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis , 2008, Histopathology.

[10]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[11]  G. Feng,et al.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. , 2007, Blood.

[12]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[13]  Hua Yu,et al.  Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.

[14]  N. Droin,et al.  Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection , 2006, Molecular and Cellular Biology.

[15]  R. Foà,et al.  Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. , 2006, American journal of human genetics.

[16]  Su-zhan Zhang,et al.  Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. , 2005, Blood.

[17]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[18]  B. Gelb,et al.  Germ-line and somatic PTPN11 mutations in human disease. , 2005, European journal of medical genetics.

[19]  G. Feng,et al.  Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[21]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.

[22]  G. Feng,et al.  The Shp-2 tyrosine phosphatase , 2004 .

[23]  G. Feng,et al.  A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis. , 2003, Blood.

[24]  B. Neel,et al.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.

[25]  J. Licht,et al.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia , 2003, Nature Genetics.

[26]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[27]  V. Poli,et al.  Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver , 2001, Molecular and Cellular Biology.

[28]  V. Poli,et al.  Erratum: Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver (Molecular and Cellcular Biology (2001) 21 (S) 1621-1632) , 2001 .

[29]  Gabriella,et al.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. , 2001, Molecular and cellular biology.

[30]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[31]  Y. Aoki,et al.  Coordinate Regulation of STAT Signaling and c-fosExpression by the Tyrosine Phosphatase SHP-2* , 1998, The Journal of Biological Chemistry.

[32]  R. Weinberg.  The Molecular Basis of Oncogenes and Tumor Suppressor Genes , 1995, Annals of the New York Academy of Sciences.

[33]  T. Pawson,et al.  SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.

[34]  J. Bishop.  Molecular themes in oncogenesis , 1991, Cell.

[35]  T. Hunter,et al.  From c-src to v-src, or the case of the missing C terminus. , 1986, Cancer surveys.

[36]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.